Literature DB >> 34949831

The placebo and nocebo effects in functional urology.

Hadi Mostafaei1,2, Sandra Jilch1, Greta Lisa Carlin1, Keiichiro Mori1,3, Fahad Quhal1,4, Benjamin Pradere1, Ekaterina Laukhtina1,5, Victor M Schuettfort1,6, Abdulmajeed Aydh1,7, Reza Sari Motlagh1,8, Claus G Roehrborn9, Shahrokh F Shariat10,11,12,13,14,15,16,17, Sakineh Hajebrahimi2.   

Abstract

A placebo is an inert substance normally used in clinical trials for comparison with an active substance. However, a placebo has been shown to have an effect on its own; commonly known as the placebo effect. A placebo is an essential component in the design of conclusive clinical trials but has itself become the focus of intense research. The placebo effect is partly the result of positive expectations of the recipient on the state of health. Conversely, a nocebo effect is when negative expectations from a substance lead to poor treatment outcomes and/or adverse events. Randomized controlled trials in functional urology have demonstrated the importance of the placebo and nocebo effects across different diseases such as overactive bladder, urinary incontinence, lower urinary tract symptoms and interstitial cystitis/painful bladder syndrome, as well as male and female sexual dysfunction. Understanding the true nature of the placebo-nocebo complex and the scope of its effect in functional urology could help urologists to maximize the positive effects of this phenomenon while minimizing its potentially negative effects.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34949831     DOI: 10.1038/s41585-021-00545-2

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  171 in total

1.  Please, please me

Authors: 
Journal:  BMJ       Date:  1999-03-13

Review 2.  The placebo effect: dissolving the expectancy versus conditioning debate.

Authors:  Steve Stewart-Williams; John Podd
Journal:  Psychol Bull       Date:  2004-03       Impact factor: 17.737

Review 3.  Neurobiological mechanisms of the placebo effect.

Authors:  Fabrizio Benedetti; Helen S Mayberg; Tor D Wager; Christian S Stohler; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2005-11-09       Impact factor: 6.167

4.  The Placebo Effect in Pain Therapies.

Authors:  Luana Colloca
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-09-14       Impact factor: 13.820

Review 5.  The placebo and its effects: A psychoneuroendocrinological perspective.

Authors:  Jens Gaab
Journal:  Psychoneuroendocrinology       Date:  2018-08-03       Impact factor: 4.905

Review 6.  Placebo and Nocebo Effects.

Authors:  Luana Colloca; Arthur J Barsky
Journal:  N Engl J Med       Date:  2020-02-06       Impact factor: 91.245

7.  Concept of true and perceived placebo effects.

Authors:  E Ernst; K L Resch
Journal:  BMJ       Date:  1995-08-26

8.  How much of the placebo 'effect' is really statistical regression?

Authors:  C J McDonald; S A Mazzuca; G P McCabe
Journal:  Stat Med       Date:  1983 Oct-Dec       Impact factor: 2.373

9.  Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus.

Authors:  Andrea W M Evers; Luana Colloca; Charlotte Blease; Marco Annoni; Lauren Y Atlas; Fabrizio Benedetti; Ulrike Bingel; Christian Büchel; Claudia Carvalho; Ben Colagiuri; Alia J Crum; Paul Enck; Jens Gaab; Andrew L Geers; Jeremy Howick; Karin B Jensen; Irving Kirsch; Karin Meissner; Vitaly Napadow; Kaya J Peerdeman; Amir Raz; Winfried Rief; Lene Vase; Tor D Wager; Bruce E Wampold; Katja Weimer; Katja Wiech; Ted J Kaptchuk; Regine Klinger; John M Kelley
Journal:  Psychother Psychosom       Date:  2018-06-12       Impact factor: 17.659

10.  Placebo in clinical trials.

Authors:  Usha Gupta; Menka Verma
Journal:  Perspect Clin Res       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.